Video Experimental Relacionado

Updated: Feb 20, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Desarrollo y Validación de Indicadores de Calidad Específicos de Cardiología para Farmacéuticos Clínicos: Un Estudio

Asma M Alshahrani¹, Mohammed Ahmed Alishaq², Manea Fares Al Munjem²

¹Department of Clinical Pharmacy, College of Pharmacy, Shaqra University, Dawadimi, Saudi Arabia.

International journal of general medicine

|February 19, 2026

Resumen

Los investigadores desarrollaron 23 indicadores de calidad para problemas de terapia medicamentosa (ICP-PTM) en cardiología, logrando un fuerte consenso entre los farmacéuticos clínicos de Arabia Saudita. Estos indicadores tienen como objetivo mejorar la atención cardiovascular y la seguridad de la medicación.

Área de la Ciencia:

Farmacología
Farmacia Clínica
Mejora de la Calidad Sanitaria

Sus antecedentes:

Los farmacéuticos clínicos son cruciales en cardiología para optimizar la terapia medicamentosa y los resultados del paciente.
La falta de indicadores de calidad estandarizados dificulta la evaluación del impacto de los farmacéuticos clínicos en cardiología.
Esta brecha requiere el desarrollo de métricas específicas para evaluar y mejorar la farmacoterapia cardiovascular.

Objetivo del estudio:

Desarrollar y validar Indicadores de Calidad para Problemas de Terapia Medicamentosa (ICP-PTM) específicos de cardiología.
Establecer indicadores de calidad relacionados con la medicación para identificar, prevenir y resolver problemas de terapia medicamentosa en la atención cardiovascular.
Lograr el consenso sobre estos indicadores utilizando una técnica Delphi modificada en Arabia Saudita.

Principales métodos:

Una revisión exhaustiva de la literatura y la consulta de grupos de expertos generaron 23 ICP-PTM candidatos.
Se empleó un enfoque Delphi modificado que involucró a 16 farmacéuticos clínicos expertos en Arabia Saudita.
Los indicadores se calificaron en una escala Likert de 9 puntos, y se requirió un consenso de ≥75% para la validación durante tres rondas.

Principales resultados:

Dieciséis farmacéuticos clínicos expertos, con amplia experiencia en cardiología, participaron en el estudio.
Los 23 ICP-PTM propuestos alcanzaron el umbral de consenso de ≥75%.
Se demostró un fuerte acuerdo con respecto a la relevancia, claridad y aplicabilidad de los ICP-PTM validados.

Conclusiones:

El estudio validó con éxito 23 ICP-PTM a través de un fuerte consenso entre los farmacéuticos clínicos de Arabia Saudita.
La implementación de estos ICP-PTM puede mejorar la calidad de la atención cardiovascular, apoyar las intervenciones de los farmacéuticos y mejorar la seguridad de la medicación.
La investigación futura debe centrarse en evaluar el impacto de estas métricas de calidad en los resultados de los pacientes.

Palabras clave:

método Delphi cardiología farmacia clínica problemas de terapia medicamentosa optimización de la medicación intervenciones dirigidas por farmacéuticos indicador de calidad–problemas de terapia medicamentosa

Más Videos Relacionados

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

Videos de Conceptos Relacionados

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Clinically Relevant Drug Product Specifications: Methods of Establishment

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...